EXAM 5 TB Pastakia Flashcards
TST testing
Positive result: acquired immune response, Latent TB, Subclinical TB, Active TB
IGRA: QuantiFERO
Positive result: acquired immune response, Latent TB, Subclinical TB, Active TB
Culture
Intermittently Positive result: Subclinical TB
Positive result: Active TB
Sputum smear
Positive/negative result: Active TB
Which LTBI medication would typically want to avoid/ be cautious with in patients living with HIV?
Rifampin – CYP inducer
Takes couple days to weeks to see effect
Drug Susceptible TB
TB strains that are sensitive to standard first-line agents
Monoresistant TB
TB strains that are sensitive to just one anti-TB drug
Polyresistant TB
TB strains that are resistant to more than one anti-TB drug but not INH and RIF
Multidrug resistant (MDR) TB
TB strains that are resistant to RIF and INH
Extensively drug-resistant (XDR) TB
Resistant to RIF and INH
+ at least one injectable agent (amikacin, kanamycin, or capreomycin)
+ any of the fluoroquinolones
Resistance in TB is slightly different than other bacteria
Spontaneous resistance occurs: why we need combo therapy
Rifampin: 10^-8
Isoniazid + pyrazinamide: 10^-6
Treatment of drug susceptible TB
Standard 6 month regimen
Rifapentine-based 4 month treatment
Standard 6 month regimen
Rifampin 600 + isoniazid 300 + ethambutol 800-1600 + pyrazinamide 1000-2000
Continuation phase: rifampin 600 + isoniazid 300 QD 18 weeks
Rifapentine-based 4 month treatment
Rifapentine 1200 + isoniazid 300 + moxifloxacin 400 + pyrazinamide 1000-2000
Continuation phase: rifapentine 1200 + isoniazid 300 + moxifloxacin 400 QD 9 weeks